LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) carries a high mortality, and efficacious therapy is lacking. Therapy using chimeric antigen receptor (CAR) T cells has been used efficaciously against hematologic malignancies, but the curative effect against solid tumors is not satisfactory. A lack of antigen tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ziming, Zheng, Xiaohu, Jiao, Defeng, Zhou, Yonggang, Sun, Rui, Wang, Baolong, Tian, Zhigang, Wei, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210386/
https://www.ncbi.nlm.nih.gov/pubmed/32405534
http://dx.doi.org/10.1016/j.omto.2020.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210386/
https://www.ncbi.nlm.nih.gov/pubmed/32405534
http://dx.doi.org/10.1016/j.omto.2020.04.008

Ejemplares similares